Withaferin A-A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases

Molecules. 2021 Apr 21;26(9):2407. doi: 10.3390/molecules26092407.

Abstract

Withaferin A (WFA) was identified as the most active phytocompound of the plant Withania somnifera (WS) and as having multiple therapeutic/ameliorating properties (anticancer, antiangiogenic, anti-invasive, anti-inflammatory, proapoptotic, etc.) in case of various diseases. In drug chemistry, WFA in silico approaches have identified favorite biological targets, stimulating and accelerating research to evaluate its pharmacological activity-numerous anticancer effects manifested in various organs (breast, pancreas, skin, colon, etc.), antivirals, anti-infective, etc., which are not yet sufficiently explored. This paper is a synthesis of the most relevant specialized papers in the field that are focused on the use of WFA in dermatological diseases, describing its mechanism of action while providing, at the same time, details about the results of its testing in in vitro/in vivo studies.

Keywords: Ayurvedic medicine; Withania somnifera; dermatological disorders; dermatology; melanoma; withaferin A.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Humans
  • Molecular Structure
  • Phytochemicals / chemistry*
  • Phytochemicals / pharmacology*
  • Plant Extracts
  • Skin / drug effects*
  • Skin / pathology
  • Structure-Activity Relationship
  • Withania / chemistry
  • Withanolides / chemistry*
  • Withanolides / pharmacology*

Substances

  • Antineoplastic Agents, Phytogenic
  • Phytochemicals
  • Plant Extracts
  • Withanolides
  • withaferin A